Sharon Bio-Medicine informs about outcome of Board Meeting

Sharon Bio-Medicine has informed that the Board of Directors of the company at its Meeting held on October 20, 2014 has resolved and allotted 1,61,11,000 Warrants to the Promoter group on Preferential basis in compliance of SEBI (Issue Of Capital And Disclosure Requirements) Regulations, 2009.

The above information is a part of company’s filings submitted to BSE.